Senseonics Holdings Shares Spike Higher; Co Reiterates FY21 Guidance; Sees FY21 Global Net Revenue To Be In Middle Of Guidance Range Of $12M-$15M
Senseonics Announces Business Updates
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM)